Delivery Order SPE2DB25D9760-SPE2DB25FXRWH
Award Date
3/3/25
Potential Completion Date
3/24/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $7,436.28, is for the delivery of the pharmaceutical product Kyleena 19.5 MG Systems. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,209.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, with a period of performance through November 27, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This is a $1,751.58 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, with a period of performance through January 30, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,815.44, is for the delivery of the pharmaceutical product "KYLEENA 19.5 MG SYSTEMS" to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of May 29, 2024 and was awarded on May 7, 2024. DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,814.82, is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. The IDC allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,478.76, is for the delivery of 4567490342 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 3, 2025. DMS Pharmaceutical Group Inc. is a key supplier in...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,919.35, is for the procurement of the pharmaceutical product Kyleena 19.5 mg systems. The contract has a period of performance through November 15, 2024 and does not utilize any set-aside designations. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $3,611.52 contract is for the delivery of the pharmaceutical product Kyleena 19.5 mg Systems. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,203.86 contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, and has an ultimate completion date of August 1, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the delivery of the pharmaceutical product Kyleena 19.5 mg systems. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery...